May 22 |
We're Not Very Worried About PepGen's (NASDAQ:PEPG) Cash Burn Rate
|
May 20 |
The Prognosis For PepGen
|
May 15 |
PepGen reports Q1 results
|
May 14 |
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
|
Apr 25 |
Best Momentum Stocks to Buy for April 25th
|
Mar 13 |
PepGen to Participate in Upcoming Investor Conferences
|
Mar 13 |
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
|
Mar 12 |
Can PepGen, Inc. (PEPG) Climb 48.62% to Reach the Level Wall Street Analysts Expect?
|
Mar 11 |
PepGen, Inc. (PEPG) Upgraded to Buy: What Does It Mean for the Stock?
|
Mar 7 |
PepGen, Inc. (PEPG) Q4 2023 Earnings Call Transcript
|